A crucial feature for immune recognition of tumour cells is surface expression of ligands for NKG2D, an activating immune receptor expressed by αβ CD8+ T cells, γδ T cells and NK cells (Groh et al., 1999; Smyth et al., 2005; Guerra et al., 2008). Here, KLRK1 is linked to neoplasm.